Overview
Fetal akinesia deformation sequence (FADS), also known as Pena-Shokeir syndrome type I, is a rare and severe condition characterized by decreased or absent fetal movement (akinesia) during pregnancy, which leads to a cascade of secondary developmental abnormalities. The lack of fetal movement results in multiple joint contractures (arthrogryposis), intrauterine growth restriction, pulmonary hypoplasia (underdeveloped lungs), short umbilical cord, and polyhydramnios (excess amniotic fluid). Facial anomalies are common and may include micrognathia (small jaw), hypertelorism (widely spaced eyes), low-set ears, and a depressed nasal tip. The condition affects multiple body systems, including the musculoskeletal, respiratory, neurological, and craniofacial systems. FADS is a clinically and genetically heterogeneous condition. It can result from any process that impairs fetal movement, including primary neuromuscular disorders (affecting the brain, spinal cord, peripheral nerves, neuromuscular junction, or muscles), connective tissue abnormalities, or restricted fetal space. Numerous genes have been implicated, including DOK7, RAPSN, MUSK, NUP88, and genes encoding acetylcholine receptor subunits (CHRNA1, CHRND, CHRNG), among others. Both autosomal recessive and, less commonly, autosomal dominant and X-linked inheritance patterns have been described, depending on the underlying genetic cause. The prognosis for FADS is generally very poor. Many affected pregnancies result in stillbirth, and most liveborn infants die in the neonatal period, primarily due to pulmonary hypoplasia and respiratory failure. There is no curative treatment; management is supportive and palliative. Prenatal diagnosis is possible through ultrasound detection of decreased fetal movements, joint contractures, and associated anomalies, and genetic testing can help identify the underlying cause for recurrence risk counseling. Families affected by FADS benefit from genetic counseling to understand the specific inheritance pattern and recurrence risk in their case.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Fetal akinesia deformation sequence.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Fetal akinesia deformation sequence at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Fetal akinesia deformation sequence.
Community
No community posts yet. Be the first to share your experience with Fetal akinesia deformation sequence.
Start the conversation →Latest news about Fetal akinesia deformation sequence
No recent news articles for Fetal akinesia deformation sequence.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Fetal akinesia deformation sequence
What is Fetal akinesia deformation sequence?
Fetal akinesia deformation sequence (FADS), also known as Pena-Shokeir syndrome type I, is a rare and severe condition characterized by decreased or absent fetal movement (akinesia) during pregnancy, which leads to a cascade of secondary developmental abnormalities. The lack of fetal movement results in multiple joint contractures (arthrogryposis), intrauterine growth restriction, pulmonary hypoplasia (underdeveloped lungs), short umbilical cord, and polyhydramnios (excess amniotic fluid). Facial anomalies are common and may include micrognathia (small jaw), hypertelorism (widely spaced eyes),
At what age does Fetal akinesia deformation sequence typically begin?
Typical onset of Fetal akinesia deformation sequence is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Fetal akinesia deformation sequence?
4 specialists and care centers treating Fetal akinesia deformation sequence are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.